MYR 0.48
(-4.95%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 21.24 Million MYR | -13.74% |
2022 | 24.62 Million MYR | 25.28% |
2021 | 19.65 Million MYR | 77.32% |
2020 | 11.08 Million MYR | 385.87% |
2019 | -3.87 Million MYR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 4.98 Million MYR | -9.81% |
2024 Q2 | 6.45 Million MYR | 29.59% |
2023 Q3 | 4.9 Million MYR | -15.73% |
2023 FY | 21.24 Million MYR | -13.74% |
2023 Q2 | 5.82 Million MYR | 16.7% |
2023 Q1 | 4.98 Million MYR | -14.26% |
2023 Q4 | 5.52 Million MYR | 12.64% |
2022 Q3 | 6.78 Million MYR | 0.0% |
2022 FY | 24.62 Million MYR | 25.28% |
2022 Q4 | 5.81 Million MYR | -14.24% |
2021 FY | 19.65 Million MYR | 77.32% |
2020 FY | 11.08 Million MYR | 385.87% |
2019 FY | -3.87 Million MYR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Artroniq Berhad | -1.88 Million MYR | 1226.352% |
QES Group Berhad | 26.64 Million MYR | 20.283% |
Pharmaniaga Berhad | 694 Thousand MYR | -2960.951% |
Apex Healthcare Berhad | 87.47 Million MYR | 75.716% |